TMDX Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against TransMedics Group, Inc. (TMDX) - Contact Kessler Topaz Meltzer & Check, LLP

Core Viewpoint - A securities class action lawsuit has been filed against TransMedics Group, Inc. for alleged misconduct during the Class Period from February 28, 2023, to January 10, 2025 [1] Allegations Against TransMedics - The complaint alleges that TransMedics engaged in kickbacks, fraudulent overbilling, and coercive tactics to generate business and revenue [3] - It is claimed that the company engaged in unsafe practices, concealed safety issues, and lacked proper safety oversight [3] - These actions purportedly exposed TransMedics to increased scrutiny and regulatory risks [3] Lead Plaintiff Process - Investors in TransMedics have until April 15, 2025, to seek appointment as a lead plaintiff representative for the class [4] - A lead plaintiff acts on behalf of all class members and is typically the investor or group of investors with the largest financial interest [4] - The decision to serve as a lead plaintiff does not affect the ability to share in any recovery [4]